Accordingly, above results indicated that melatonin enhances the anti-proliferative action of β-catenin or HDACs inhibitor on ESCC cells via hindering the HDAC7-β-catenin-c-Myc signaling. This evidence concerns the gene MYC and esophageal squamous cell carcinoma.